PBD Biotech
PBD Biotech is developing phage-based diagnostics for mycobacteria to achieve the goals of the World Health Oraganization's "End TB Strategy".
Latest PBD Biotech Content
Product News
Actiphage Enters New Clinical Trial Aimed at Early Tuberculosis Diagnosis
A new clinical trial of a ground-breaking phage-based molecular diagnostic, has been agreed. The trial is aimed at evaluating the performance of the phage assay as a first-line blood-based diagnostic for active pulmonary Tuberculosis.
Industry Insight
Exploiting Bacteriophage as a Diagnostic Tool
Technology Networks spoke to Dr. Tomas Richardson from PBD Biotech, to hear more about how bacteriophage can be used to diagnose tuberculosis in both humans and cattle.
Advertisement
